Do Decision Aids Benefit Patients with Chronic Musculoskeletal Pain? A Systematic Review

OBJECTIVE

To review the effect of patient decision aids for adults making treatment decisions regarding the management of chronic musculoskeletal pain.

METHODS

We performed a systematic review of randomized controlled trials of adults using patient decision aids to make treatment decisions for chronic musculoskeletal pain in the outpatient setting.

RESULTS

Of 477 records screened, 17 met the inclusion criteria. Chronic musculoskeletal pain conditions included osteoarthritis of the hip, knee, or trapeziometacarpal joint and back pain. Thirteen studies evaluated the use of a decision aid for deciding between surgical and nonsurgical management. The remaining four studies evaluated decision aids for nonsurgical treatment options. Outcomes included decision quality, pain, function, and surgery utilization. The effects of decision aids on decision-making outcomes were mixed. Comparing decision aids with usual care, all five studies that examined knowledge scores found improvement in patient knowledge. None of the four studies that evaluated satisfaction with the decision-making process found a difference with use of a decision aid. There was limited and inconsistent data on other decision-related outcomes. Of the eight studies that evaluated surgery utilization, seven found no difference in surgery rates with use of a decision aid. Five studies made comparisons between different types of decision aids, and there was no clearly superior format.

CONCLUSIONS

Decision aids may improve patients' knowledge about treatment options for chronic musculoskeletal pain but largely did not impact other outcomes. Future efforts should focus on improving the effectiveness of decision aids and incorporating nonpharmacologic and nonsurgical management options.

Development and Pilot Testing of a Mobile Based Patient Decision Aid for Childbirth Decision Making

INTRODUCTION

Patient Decision Aids (PtDA) facilitates Shared Medical Decision-Making (SDM). This study aims to facilitate the childbirth decision-making process by a decision aid mobile application.

METHOD

The model development process for decision aids was used and a master group supervised it. The assessment of study was made by a face-to-face interview and prototype was also developed for it. Then Alpha test was performed with 10 pregnant women and 10 experts. 60 pregnant women and 9 clinical professionals participated in a beta test.

RESULT

The modules of our PtDA consisted of health record, decision aid, educational content, frequently asked questions and help. The result of alpha test revealed that this system had high usability. After increasing intervention, the intervention group had more knowledge of women in comparison with the control group. Moreover, the reduction of decisional conflict in the intervention group was statistically significant compared with the control group. In addition, the preference for women was changed from cesarean section (CS) to vaginal delivery in the intervention group. In the beta test, the result of the ultimate usability evaluation showed that this system was usable and easy.

CONCLUSION

According to the results, it seems that PtDAs can be effective for empowering women in order to choose the mode of delivery.

Development of a web-based patient decision aid for initiating disease modifying anti-rheumatic drugs using user-centred design methods

Background

A main element of patient-centred care, Patient Decision Aids (PtDAs) facilitate shared decision-making (SDM). A recent update of the International Patient Decision Aids Standards (IPDAS) emphasised patient involvement during PtDA development, but omitted a methodology for doing so. This article reports on the value of user-centred design (UCD) methods for the development of a PtDA that aims to support inflammatory arthritis patients in their choice between disease modifying anti-rheumatic drugs (DMARDs).

Methods

The IPDAS development process model in combination with UCD methods were applied. The process was overseen by an eight-member multidisciplinary steering group. Patients and health professionals were iteratively consulted. Qualitative in-depth interviews combined with rapid prototyping were conducted with patients to assess their needs for specific functionality, content and design of the PtDA. Group meetings with health professionals were organized to assess patients’ needs and to determine how the PtDA should be integrated into patient pathways. The current literature was reviewed to determine the clinical evidence to include in the PtDA. To evaluate usability among patients, they were observed using the PtDA while thinking aloud and then interviewed.

Results

The combination of patient interviews with rapid prototyping revealed that patients wanted to compare multiple DMARDs both for their clinical aspects and implications for daily life. Health professionals mainly wanted to refer patients to a reliable, easily adjustable source of information about DMARDs. A web-based PtDA was constructed consisting of four parts: 1) general information about SDM, inflammatory arthritis and DMARDs; 2) an application to compare particular DMARDs; 3) value clarification exercises; and 4) a printed summary of patients’ notes, preferences, worries and questions that they could bring to discuss with their rheumatologist.

Conclusions

The study demonstrated that UCD methods can be of great value for the development of PtDAs. The early, iterative involvement of patients and health professionals was helpful in developing a novel user-friendly PtDA that allowed patients to choose between DMARDs. The PtDA fits the values of all stakeholders and easily integrates with the patient pathway and daily workflow of health professionals. This collaborative designed PtDA may improve SDM and patient participation in arthritis care.

Electronic supplementary material

The online version of this article (doi:10.1186/s12911-017-0433-5) contains supplementary material, which is available to authorized users.